These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6747020)

  • 1. The effects of five potassium chloride preparations on the upper gastrointestinal mucosa in healthy subjects receiving glycopyrrolate.
    Alsop WR; Moore JG; Rollins DE; Tolman KG
    J Clin Pharmacol; 1984; 24(5-6):235-9. PubMed ID: 6747020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of potassium chloride supplements on upper gastrointestinal mucosa.
    McMahon FG; Ryan JR; Akdamar K; Ertan A
    Clin Pharmacol Ther; 1984 Jun; 35(6):852-5. PubMed ID: 6734038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper gastrointestinal lesions after potassium chloride supplements: a controlled clinical trial.
    McMahon FG; Ryan JR; Akdamar K; Ertan A
    Lancet; 1982 Nov; 2(8307):1059-61. PubMed ID: 6127542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral potassium supplements on upper gastrointestinal mucosa: multicenter clinical comparison of three formulations and placebo.
    Sinar DR; Bozymski EM; Blackshear JL
    Clin Ther; 1986; 8(2):157-63. PubMed ID: 3698061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic evaluation of slow-release potassium chloride preparations.
    Kendall C; Krantz KD; Berger A; Sharp T
    Clin Pharmacol Ther; 1985 Jul; 38(1):28-30. PubMed ID: 3891194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of oral potassium chloride on upper gastrointestinal mucosa in healthy subjects: healing of lesions despite continuing treatment.
    Moore JG; Alsop WR; Freston JW; Tolman KG
    Gastrointest Endosc; 1986 Jun; 32(3):210-2. PubMed ID: 3522347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroscopic localization of a microencapsulated KCl preparation in the human stomach.
    Graham DY; Smith JL; Jones RD; Rakhit A; Tipnis V; Hurley ME
    Gastrointest Endosc; 1987 Jun; 33(3):220-3. PubMed ID: 3297914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irritative properties of two clinical potassium chloride formulations on duodenal mucosa of the cat and esophageal mucosa of the opossum.
    Alphin RS; O'Dell SW; Sancilio LF; Ward JW
    Dig Dis Sci; 1984 Jun; 29(6):508-12. PubMed ID: 6723482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What happens to tablets and capsules in the stomach: endoscopic comparison of disintegration and dispersion characteristics of two microencapsulated potassium formulations.
    Graham DY; Smith JL; Bouvet AA
    J Pharm Sci; 1990 May; 79(5):420-4. PubMed ID: 2352162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of potassium-magnesium citrate on upper gastrointestinal mucosa.
    Gonzalez GB; Pak CY; Adams-Huet B; Taylor R; Bilhartz LE
    Aliment Pharmacol Ther; 1998 Jan; 12(1):105-10. PubMed ID: 9692708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid and solid potassium chloride: bioavailability and safety.
    Skoutakis VA; Acchiardo SR; Wojciechowski NJ; Carter CA
    Pharmacotherapy; 1984; 4(6):392-7. PubMed ID: 6514589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the ulcerogenic effect of potassium chloride by endoscopy and fecal blood loss.
    Lech Y; Hey H; Jørgensen F; Matzen P; Ostergaard O
    J Clin Pharmacol; 1987 Mar; 27(3):206-9. PubMed ID: 3680575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal irritant potential of a potassium-sparing diuretic and of wax-matrix potassium chloride.
    Ryan JR; McMahon FG; Akdamar K; Ertan A; Agrawal N
    Clin Pharmacol Ther; 1984 Jan; 35(1):90-3. PubMed ID: 6690174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on upper gastrointestinal mucosa of three delivery systems of potassium as supplement to frusemide administration.
    McLoughlin JC
    J R Soc Med; 1985 Jun; 78(6):459-62. PubMed ID: 3999081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects.
    Stoltz RR; Harris SI; Kuss ME; LeComte D; Talwalker S; Dhadda S; Hubbard RC
    Am J Gastroenterol; 2002 Jan; 97(1):65-71. PubMed ID: 11808971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potassium chloride preparations and fecal blood loss. A parallel study with a 10 percent solution and a non-enteric-coated waxy-matrix tablet.
    Rider JA; Manner RJ; Swader JI
    JAMA; 1975 Feb; 231(8):836-7. PubMed ID: 1172753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic comparison of solid and liquid potassium chloride supplements.
    Patterson DJ; Weinstein GS; Jeffries GH
    Lancet; 1983 Nov; 2(8358):1077-8. PubMed ID: 6138615
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of microencapsulated vs. enteric-coated acetylsalicylic acid on gastric and duodenal mucosa: an endoscopic study.
    Malfertheiner P; Stanescu A; Rogatti W; Ditschuneit H
    J Clin Gastroenterol; 1988 Jun; 10(3):269-72. PubMed ID: 2980760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jejunal ulceration and stricture due to wax-matrix potassium chloride tablets and amitriptyline.
    Bronson DL; Gamelli RL
    J Clin Pharmacol; 1987 Oct; 27(10):788-9. PubMed ID: 3429685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulceration of the small intestine due to slow-release potassium chloride tablets.
    Leijonmarck CE; Räf L
    Acta Chir Scand; 1985; 151(3):273-8. PubMed ID: 4013604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.